(CNXC) Concentrix - Ratings and Ratios
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US20602D1019
CNXC: Customer, Experience, Solutions, Technology, Analytics, Services
Concentrix Corporation, a leader in the customer experience (CX) solutions space, offers a comprehensive suite of services designed to enhance client interactions through technology. Their services encompass CX process optimization, automation across front and back offices, advanced analytics, and business transformation, all delivered through multiple communication channels including voice, chat, email, and social media.
The company serves a diverse range of industries such as technology, retail, banking, healthcare, and communications, providing tailored solutions to each sector. This diversification underscores Concentrixs adaptability and robust service offerings, making it a preferred partner for industries seeking to elevate their customer engagement strategies.
From a financial perspective, Concentrix boasts a market capitalization of approximately $3.1 billion, reflecting its established presence in the market. The trailing P/E ratio of 13.08 indicates a reasonable valuation relative to its earnings, while the forward P/E of 4.09 suggests investor optimism about its future growth prospects. The price-to-book ratio of 0.76 points to a potential undervaluation, which could be attractive for value investors. Additionally, the price-to-sales ratio of 0.33 highlights the companys efficient revenue generation relative to its market value, a favorable metric for investors focusing on operational efficiency.
Concentrixs strategic focus on integrating AI and digital transformation positions it well to capitalize on the growing demand for intelligent and automated customer solutions. This strategic positioning, combined with its broad client base and efficient operations, presents a compelling investment opportunity for those seeking exposure to the evolving customer experience management landscape.
Additional Sources for CNXC Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
CNXC Stock Overview
Market Cap in USD | 3,084m |
Sector | Technology |
Industry | Information Technology Services |
GiC Sub-Industry | Data Processing & Outsourced Services |
IPO / Inception | 2020-11-24 |
CNXC Stock Ratings
Growth Rating | -55.0 |
Fundamental | 54.7 |
Dividend Rating | 66.4 |
Rel. Strength | -19.1 |
Analysts | 4/5 |
Fair Price Momentum | 43.46 USD |
Fair Price DCF | 174.70 USD |
CNXC Dividends
Dividend Yield 12m | 2.52% |
Yield on Cost 5y | 1.67% |
Annual Growth 5y | 49.23% |
Payout Consistency | 100.0% |
CNXC Growth Ratios
Growth Correlation 3m | -20.6% |
Growth Correlation 12m | -61.6% |
Growth Correlation 5y | -83.6% |
CAGR 5y | -9.69% |
CAGR/Max DD 5y | -0.12 |
Sharpe Ratio 12m | -0.86 |
Alpha | -21.05 |
Beta | 0.751 |
Volatility | 75.70% |
Current Volume | 783.2k |
Average Volume 20d | 1127.5k |
As of April 12, 2025, the stock is trading at USD 48.82 with a total of 783,230 shares traded.
Over the past week, the price has changed by +1.14%, over one month by +6.87%, over three months by +5.08% and over the past year by -16.98%.
Partly, yes. Based on ValueRay Fundamental Analyses, Concentrix (NASDAQ:CNXC) is currently (April 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 54.67 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CNXC as of April 2025 is 43.46. This means that CNXC is currently overvalued and has a potential downside of -10.98%.
Concentrix has received a consensus analysts rating of 4.00. Therefor, it is recommend to buy CNXC.
- Strong Buy: 2
- Buy: 2
- Hold: 2
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, CNXC Concentrix will be worth about 46.9 in April 2026. The stock is currently trading at 48.82. This means that the stock has a potential downside of -3.87%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 64.3 | 31.8% |
Analysts Target Price | 72.2 | 47.8% |
ValueRay Target Price | 46.9 | -3.9% |